EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Anti-GM-CSF autoantibodies predict outcome of cryptococcal meningitis in patients not infected with HIV: A cohort study

Ying-Kui Jiang, Ling-Hong Zhou, Jia-Hui Cheng, Jun-Hao Zhu, Yu Luo, Li Li, Min Zhu, Rong-Sheng Zhu, Wen-Jia Qiu, Hua-Zhen Zhao, Xuan Wang, Jun-Tian Huang und 3 weitere

Clinical Microbiology and Infection · 2024

DOI: 10.1016/j.cmi.2024.01.018 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Microbiology and Infection, 2024. Verfasst von Ying-Kui Jiang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infec…. Hauptthemen laut MEDLINE: Autoantibodies, Granulocyte-Macrophage Colony-Stimulating Factor, Meningitis, Cryptococcal. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To explore the seroprevalence of anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibodies in non-HIV cryptococcal meningitis (CM) and assess its predictive value for survival. METHODS: This is a retrospective study of 12 years of non-HIV CM. We detected serum anti-GM-CSF autoantibodies, and evaluated the clinical features and outcomes, together with the exploration of prognostic factors for 2-week and 1-year survival. RESULTS: A total of 584 non-HIV CM cases were included. 301 of 584 patients (51.5%) were phenotypically healthy. 264 Cryptococcus isolates were obtained from cerebrospinal fluid (CSF) culture, of which 251 were identified as C. neoformans species complex and 13 as C. gattii species complex. Thirty-seven of 455 patients (8.1%) tested positive for serum anti-GM-CSF autoantibodies. Patients with anti-GM-CSF autoantibodies were more susceptible to C. gattii species complex infection (66.7% vs. 6.3%; p 3 centimetres (42.9% vs. 6.5%; p 0.001). Of 584 patients 16 (2.7%) died within 2 weeks, 77 of 563 patients (13.7%) died at 1 year, and 93 of 486 patients (19.1%) lived with disabilities at 1 year. Univariant Cox regression analysis found that anti-GM-CSF autoantibodies were associated with lower 1-year survival (HR, 2.66; 95% CI, 1.34-5.27; p 0.005). Multivariable Cox proportional hazards modelling revealed that CSF cryptococcal antigen titres ≥1:1280 were associated with both, reduced 2-week and 1-year survival rates (HR, 5.44; 95% CI, 1.23-24.10; p 0.026 and HR, 5.09; 95% CI, 1.95-13.26; p 0.001). DISCUSSION: Presence of serum anti-GM-CSF autoantibodies is predictive of poor outcomes, regardless of host immune status and the causative Cryptococcus species complex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesGranulocyte-Macrophage Colony-Stimulating FactorMeningitis, CryptococcalAdultFemaleHumansMaleMiddle AgedCryptococcus gattiiCryptococcus neoformansPrognosisRetrospective StudiesSeroepidemiologic Studies

Stichwörter der Autor:innen

Anti-GM-CSF autoantibodiesCryptococcal meningitisNon-HIVPrognostic factorsSurvival

Substanzen

AutoantibodiesGranulocyte-Macrophage Colony-Stimulating Factor

Autor:innen und Institutionen

  • Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • The Center for Medical Mycology, Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
  • Department I of Internal Medicine, University Hospital of Cologne, and Faculty of Medicine, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECA…
  • Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China. E…

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Jiang, Y. K., Zhou, L. H., Cheng, J. H., Zhu, J. H., Luo, Y., Li, L., Zhu, M., Zhu, R. S., Qiu, W. J., Zhao, H. Z., Wang, X., Huang, J. T., Cornely, O. A., Zhang, W. H., & Zhu, L. P. (2024). Anti-GM-CSF autoantibodies predict outcome of cryptococcal meningitis in patients not infected with HIV: A cohort study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2024.01.018

Vancouver

Jiang YK, Zhou LH, Cheng JH, Zhu JH, Luo Y, Li L, et al. Anti-GM-CSF autoantibodies predict outcome of cryptococcal meningitis in patients not infected with HIV: A cohort study. Clinical Microbiology and Infection. 2024. doi:10.1016/j.cmi.2024.01.018

BibTeX
@article{Jiang2024,
  author = {Jiang, Ying-Kui and Zhou, Ling-Hong and Cheng, Jia-Hui and Zhu, Jun-Hao and Luo, Yu and Li, Li and Zhu, Min and Zhu, Rong-Sheng and Qiu, Wen-Jia and Zhao, Hua-Zhen and Wang, Xuan and Huang, Jun-Tian and Cornely, Oliver A and Zhang, Wen-Hong and Zhu, Li-Ping},
  title = {Anti-GM-CSF autoantibodies predict outcome of cryptococcal meningitis in patients not infected with HIV: A cohort study},
  journal = {Clinical Microbiology and Infection},
  year = {2024},
  doi = {10.1016/j.cmi.2024.01.018}
}
Kostenlos starten →